| Gene symbol | TNFRSF10B | Synonyms | CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8p21.3 | dbXrefs | |
| Description | TNF receptor superfamily member 10b | ||||
| Gene symbol | EGFR | Synonyms | ERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7p11.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | epidermal growth factor receptor | ||||
| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC2108 |
| Trial ID | NCT03941626 |
| Disease | Stomach Cancer | Liver Cancer | Esophageal Cancer | Brain Glioma |
| Altered gene | EGFR|DR5|NY-ESO-1|MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | Shenzhen BinDeBio Ltd. |
| Other ID(s) | 2019BDB016 |
| Cohort 1 | |||||||||||
|
|||||||||||